Advertisement
Home Tags Cancer: Colon

Tag: Cancer: Colon

Continuing a centralized mailed fecal occult blood test program is beneficial for improving adherence to colorectal cancer screening

Continuing Mailed FOBT Program Ups CRC Screening Adherence

0
Continuing benefits for patients who completed FOBT tests in years one and/or two of the program
Processed meats

WHO: Evidence That Processed Meat Can Cause Cancer

0
Meanwhile, red meat only shows some association with an increased risk for colorectal cancer
For patients with colorectal cancer

SNORA42 Identified as Novel Oncogene in Colorectal Cancer

0
Increased SNORA42 expression is independent prognostic factor for overall, disease-free survival
For patients with metastatic colorectal cancer

Extended RAS Testing Urged Before EGFR MoAB Therapy

0
Extended testing recommended for mutations in KRAS, NRAS in patients with metastatic CRC
Most patients undergoing surgery for lung or colorectal cancer believe that the surgery is likely to be curative

Most Cancer Patients Believe Surgery Will Be Curative

0
Findings even among patients with stage IV lung, colorectal cancer
The U.S. Preventive Services Task Force (USPSTF) recommends colorectal cancer screening starting at age 50 years and continuing through age 75 years. These findings form the basis of a draft recommendation statement

USPSTF Recommends CRC Screening for 50- to 75-Year-Olds

0
Grade A recommendation for 50- to 75-year-olds; individualized decision urged for those age 76 to 85
Daily aspirin might extend survival for patients with cancers of the gastrointestinal tract

More Evidence Daily Aspirin May Protect Against GI Cancer

0
Four-year study found survival doubled for GI cancer patients who took low-dose pill each day
The combination pill Lonsurf (trifluridine and tipiracil) has been approved by the U.S. Food and Drug Administration to treat metastatic colorectal cancer in patients who aren't responding to other treatments

FDA Approves Lonsurf for Metastatic Colorectal Cancer

0
For patients with metastatic CRC previously treated with chemotherapy, biological therapy
Given its high cost

Regorafenib Deemed Not Cost-Effective for Metastatic CRC

0
Findings based on its use as third-line treatment of metastatic colorectal cancer
Electronic health record-based triggers may cut time to diagnostic evaluation of colorectal and prostate cancer

EHR Triggers Cut Time to Diagnostic Cancer Evaluation

0
Findings among veterans flagged for delayed diagnosis of prostate, colorectal cancer